All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
Read the Investors Guide To Newly Emerging Marijuana Markets 
LEARN MORE
600x300
How These Canadian Companies Are Preparing for Potential $6 Billion Market
The Canadian recreational cannabis market is one of the most exciting markets in the world. We look at how companies are positioning themselves, and identify one small recreational brand to have a look at.
13x13x1 READ MORE
600x300
Peace Naturals Receives Dealer's License Allowing for the Exportation of New Product Categories
Cronos Group Inc. (TSXV: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) is pleased to announce that Peace Naturals Project Inc., a licensed producer wholly owned by the Company, has just obtained a Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada.
13x13x1 READ MORE
600x300
CanniMed Therapeutics Announces Continuation of Discussions with Aurora
CanniMed Therapeutics Inc. (TSX:CMED) announces that it is continuing to discuss terms of a possible transaction with Aurora Cannabis Inc.
13x13x1 READ MORE
600x300
Namaste Receives Health Canada Confirmation of Readiness
Namaste Technologies Inc. (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that Health Canada’s Office of Medical Cannabis has provided the Company with a Confirmation of Readiness for a license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the Company’s wholly owned subsidiary, Cannmart Inc.
13x13x1 READ MORE
600x300
Abattis Partners with Vancouver-Based Craft Brewer to Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer
Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) is pleased to announce the formation of a new partnership with Faculty Brewing Co., a Vancouver-based craft brewery, to develop a hemp-infused, cannabinoid-rich, THC-free craft beer.
13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
 
32x32x1   32x32x2   32x32x3
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2018, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.